StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Noncurrent Portion of RMB-Denominated Bank Loans by Year

Noncurrent Portion of RMB-Denominated Bank Loans (RMB M) (M)

BeOne Medicines Noncurrent Portion of RMB-Denominated Bank Loans: 1,215M in FY2024, down 13.4% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2024
1,215
Period ended Dec 31, 2024
Change on a year earlier
-13.4%
1,403 in FY2023
History
6 years
Since FY2019
Sources
5
Documents cited below

Where the FY2024 figure comes from

Source: Form 10-K (filed 2025-02-27) ↗

Reported in Form 10-Q / 10-K Debt Note (XBRL, CNY Measure).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNoncurrent Portion of RMB-Denominated Bank Loans (RMB M) (M)Year on yearSource
FY2024Dec 31, 20241,215-13.4%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 20231,403-2.8%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 20221,443+12.0%Form 10-K (filed 2024-02-26) ↗
FY2021Dec 31, 20211,288+7.5%Form 10-K (filed 2023-02-27) ↗
FY2020Dec 31, 20201,198+106.6%Form 10-K (filed 2022-02-28) ↗
FY2019Dec 31, 2019580–Form 10-K (filed 2021-02-25) ↗

Cite this data

StockData. (2026). BeOne Medicines Noncurrent Portion of RMB-Denominated Bank Loans (M), annual FY2019–FY2024 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/lt-debt-nc-cny

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.